Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Westcore Small-Cap Growth Fund II Retail Class (WTSLX)

20.87
Net Asset Value
+0.53%
1 Day
+3.57%
Year-to-Date
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
1.10%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to achieve long-term capital appreciation by investing primarily in small-capitalization growth companies. Under normal circumstances, the fund invests at least eighty percent (80%) of the value of its net assets plus any borrowings for investment purposes in small-capitalization companies. The adviser expects to only invest in securities of companies whose stock is traded on U.S. markets, including depository receipts or shares issued by companies incorporated outside of the United States (e.g., ADRs).

Performance

1 month+1.46% 3 years-5.99%
3 months+2.81% 5 years+1.21%
1 year+7.74% Since inception+8.91%
Data through --

Peer Comparisonvs. Mid-cap growth

 WTSLXCategory
Performance 5-yr return+1.21%+11.79%
Expense ratio1.10%1.26%
Risk 5 year sharpe ratio0.170.94
Net assets$36.1M$1.2B
Average market cap$12.2B$9.8B
Average P/E26.026.6
Portfolio turnover67%67%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyWestcore
Fund manager & tenureMitch Begun / 0 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock95.27%
International stock3.34%
Cash1.39%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer service 18.88%
Healthcare 18.48%
Energy 14.91%
Industrial materials 14.59%
Hardware 10.51%
Top 10 Holdings
Portfolio weighting
FISV Fiserv Inc5.43%
ROST Ross Stores Inc5.29%
ISRG Intuitive Surgical5.04%
WYNN Wynn Resorts4.76%
URI United Rentals Inc4.32%
A Agilent Technologies Inc4.27%
EXPE Expedia Inc4.11%
BMRN Biomarin Pharmaceutical Inc3.96%
TDG TransDigm Group Inc3.80%
CBOE CBOE Holdings Inc3.70%